Modular facilities can be an effective way for drug developers and manufacturers to reduce costs, minimize delays, and expedite time-to-market, by utilizing the available infrastructure while operating in accordance with the standard GMP guidelines Roots Analysis has announced the addition of “Modular Facilities in Pharmaceutical and Biotech Market (3rd Edition), 2023-2035” report to its list of offerings.